title: Vascular endothelial growth factor (VEGF), VEGF receptors expression and microvascular density in benign and malignant thyroid diseases.
abstract: Angiogenesis is critical for the growth and metastatic spread of tumours. Vascular endothelial growth factor (VEGF) is the most potent inducer of neovasculature, and its increased expression has been related to a worse clinical outcome in many diseases. The purpose of this study was to evaluate the relation between VEGF, its receptors (VEGFR-1 and VEGFR-2) and microvessel density (MVD) in thyroid diseases. Immunostaining for VEGF and VEGF receptors was performed in 66 specimens of thyroid tissue, comprising 17 multinodular goitre (MNG), 14 Graves' disease, 10 follicular adenoma, 8 Hashimoto's thyroiditis, 7 papillary carcinoma and 10 normal thyroid specimens. Thyrocyte positivity for VEGF and VEGF receptors was scored 0-3. Immunohistochemistry for CD31, and CD34 on the same sections was performed to evaluate MVD. Immunohistochemical staining of VEGF in thyrocytes was positive in 92% of all the thyroid tissues studied. Using an immunostaining intensity cut off of 2, increased thyrocyte staining was seen in follicular adenoma specimens, MNG and normal thyroids compared with Hashimoto's thyroiditis and Graves' disease (P < 0.05). Similarly, VEGF thyrocyte expression in Graves' disease was less than other pathologies (P < 0.05). VEGFR-1 expression and the average MVD score did not differ between the different thyroid pathologies. VEGF expression was lower in autoimmune pathologies compared to autonomous growth processes. Conversely, both VEGFR-1 and VEGFR-2 were widely expressed in benign and neoplastic thyroid disease, suggesting that the up-regulation of VEGF and not its receptors occurs as tissue becomes autonomous. There was no clear relationship between MVD measurement and thyroid pathology.
authors: Department of Otolaryngology, Hull Royal Infirmary, Hull, UK.
authors: Ala'eddin
authors: A
authors: Jebreel
authors: James
authors: J
authors: England
authors: Karen
authors: K
authors: Bedford
authors: Justin
authors: J
authors: Murphy
authors: Laszlo
authors: L
authors: Karsai
authors: Stephen
authors: S
authors: Atkin
mesh_terms: D006801:Humans; D007124:Immunoenzyme Techniques; D009389:Neovascularization, Pathologic / Q000378:metabolism* / Q000473:pathology; D040262:Receptors, Vascular Endothelial Growth Factor / Q000378:metabolism*; D013959:Thyroid Diseases / Q000378:metabolism*; D013961:Thyroid Gland / Q000098:blood supply* / Q000378:metabolism; D013964:Thyroid Neoplasms / Q000098:blood supply / Q000378:metabolism; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism*; D040281:Vascular Endothelial Growth Factor Receptor-1 / Q000378:metabolism; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000378:metabolism
chemical_list: C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D040262:Receptors, Vascular Endothelial Growth Factor; D040281:Vascular Endothelial Growth Factor Receptor-1; D040301:Vascular Endothelial Growth Factor Receptor-2
references: Am J Pathol. 1993 Aug;143(2):401-9
references: 7688183
references: J Endocrinol. 1998 Apr;157(1):5-12
references: 9614352
references: J Clin Oncol. 1995 Feb;13(2):477-81
references: 7531224
references: Cancer Res. 1995 Sep 15;55(18):3964-8
references: 7664263
references: J Natl Cancer Inst. 1995 Nov 1;87(21):1603-12
references: 7563203
references: Oncogene. 1995 Oct 19;11(8):1569-79
references: 7478581
references: Breast Cancer Res Treat. 1995;36(2):193-204
references: 8534867
references: Cancer. 1996 Mar 1;77(5):858-63
references: 8608475
references: Surgery. 1996 Mar;119(3):333-9
references: 8619189
references: Mod Pathol. 1996 Jun;9(6):636-41
references: 8782200
references: J Surg Oncol. 1996 Oct;63(2):95-8
references: 8888801
references: J Natl Cancer Inst. 1997 Jan 15;89(2):139-47
references: 8998183
references: Cancer. 1997 Jan 15;79(2):206-13
references: 9010092
references: Nature. 1997 Apr 17;386(6626):671-4
references: 9109485
references: J Clin Endocrinol Metab. 1997 Jun;82(6):1968-73
references: 9177415
references: Br J Cancer. 1997;76(7):930-4
references: 9328154
references: J Clin Endocrinol Metab. 1997 Nov;82(11):3741-7
references: 9360534
references: Br J Cancer. 1997;76(9):1221-7
references: 9365173
references: Am J Surg. 1997 Nov;174(5):513-7
references: 9374227
references: J Pathol. 1998 Jan;184(1):53-7
references: 9582527
references: Am J Pathol. 1999 Dec;155(6):1967-76
references: 10595926
references: Thyroid. 2000 Apr;10(4):349-57
references: 10807064
references: Hum Pathol. 2000 Apr;31(4):439-42
references: 10821490
references: J Endocrinol. 2000 Sep;166(3):475-80
references: 11029748
references: Ann Surg. 2001 Feb;233(2):227-35
references: 11176129
references: Hum Pathol. 2001 Jan;32(1):10-7
references: 11172289
references: J Clin Endocrinol Metab. 2001 Feb;86(2):656-8
references: 11158026
references: IUBMB Life. 2001 Jul;52(1-2):61-6
references: 11795595
references: Anticancer Res. 2001 Nov-Dec;21(6B):4221-9
references: 11908675
references: Biol Chem. 2002 Oct;383(10):1573-9
references: 12452433
references: Cancer Res. 2002 Dec 15;62(24):7284-90
references: 12499271
references: J Mol Med (Berl). 2003 Jan;81(1):20-31
references: 12545246
references: Endocrinology. 2004 Feb;145(2):817-22
references: 14605010
references: Thyroid. 2006 Jun;16(6):545-54
references: 16839256
references: Endocr Relat Cancer. 2006 Sep;13(3):931-44
references: 16954441
references: Lancet. 1992 Nov 7;340(8828):1120-4
references: 1279332
references: J Natl Cancer Inst. 1992 Dec 16;84(24):1875-87
references: 1281237
references: Endocrinology. 1978 Dec;103(6):2306-14
references: 748050
references: N Engl J Med. 1991 Jan 3;324(1):1-8
references: 1701519
references: Endocr Rev. 1992 Feb;13(1):18-32
references: 1372863
references: Oncol Rep. 1998 Nov-Dec;5(6):1343-8
references: 9769366
references: J Clin Endocrinol Metab. 1998 Nov;83(11):3908-12
references: 9814467
references: Am J Surg. 1998 Nov;176(5):442-7
references: 9874430
references: Eur Urol. 1999 Jan;35(1):2-8
references: 9933788
references: J Endocrinol. 1999 Apr;161(1):41-9
references: 10194527
references: Hum Pathol. 1999 Aug;30(8):891-7
references: 10452500
references: J Thorac Cardiovasc Surg. 1998 May;115(5):1007-14
references: 9605068
references: J Cancer Res Clin Oncol. 1994;120(11):651-6
references: 7525593